Gravar-mail: PP62. DO THE RESPONSE ASSESSMENTS ON MRI SCAN PERFORMED AFTER TWO CYCLES OF BEVACIZUMAB (AVASTIN) CORRELATE WITH OVERALL SURVIVAL AND NEUROLOGICAL IMPROVEMENTS IN PATIENTS WITH GLIOBLASTOMA?